Business ❯ Finance ❯ Investments ❯ Market Analysis

AI Stocks

EU Grants Conditional Approval for ImmunityBio’s Anktiva in BCG‑Unresponsive Bladder Cancer

The decision extends Anktiva’s reach across Europe to reinforce ImmunityBio’s commercial transition.

Coinbase Posts $667 Million Q4 Loss as Trading Slumps and Crypto Holdings Are Marked Down

ASML Sets Records and Lifts 2026 Outlook on AI Tool Demand, Plans 1,700 Job Cuts

Qualivian’s Q3 Letter Highlights Outsized Long-Term Gains, AI-Driven Quarter and Portfolio Shift

CoreWeave Jumps After DOE “Genesis Mission” Win, Fueled by Heavy Short-Covering

Rivian Beats Q3, Reaffirms 2025 Outlook as R2 Stays on Track for 2026

Alibaba Extends 2025 Rally as JPMorgan Lifts Target on AI Push

Nvidia Takes $5 Billion Stake in Intel, Announces Multi-Generation Chip Collaboration